Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 9:57 PM
Study NCT ID:
NCT05657158
Status:
COMPLETED
Last Update Posted:
2022-12-20
First Post:
2022-11-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-16
First Submit QC Date:
None
Study First Post Date:
2022-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-19
Last Update Post Date:
2022-12-20
Last Update Post Date Type:
ACTUAL